Nonalcoholic fatty liver disease (NAFLD) is a chronic metabolic liver disease closely related
to obesity, which has become a global health problem. However, current pharmacological …

Hypoxia, a low environmental oxygen level, is a common problem in the ocean globally.
Hypoxia has been known to cause disruption to the endocrine system of marine organisms …

Allomyrina dichotoma larva is a nutritional-worthy future food resource and it contributes to
multiple pharmacological functions. However, its antidiabetic effect and molecular …

Metabolic syndrome is a complex disease that involves multiple organ systems including a
critical role for the liver. Non-alcoholic fatty liver disease (NAFLD) is a key component of the …

The present study aimed to evaluate the potential synergistic and protective effects of
ALM16, a mixture of Astragalus membranaceus (AM) and Lithospermum erythrorhizon (LE) …

Background: Vancomycin is a glycopeptide antibiotic with a high risk of acute liver injury.
Resveratrol is believed to protect the liver against toxicity. Aim: To investigate the ability of …

Using the latest available artificial intelligence (AI) technology, an advanced algorithm
LIVERFAStTM has been used to evaluate the diagnostic accuracy of machine learning (ML) …

Background Nonalcoholic fatty liver disease (NAFLD) is a complex disease which is
characterized by the deposition of fats in the hepatocytes. Further, it progresses to …

Energy restriction reduces liver fat, improves hepatic insulin resistance and lipid metabolism.
However, temporal data in which these metabolic improvements occur and their interplay is …

We previously reported the potential anti-obesity effects of the water extract of Hydrangea
serrata (Thunb.) Ser. leaves (WHS) in high-fat diet-induced obese mice. As an extension of …